Literature DB >> 3942964

Pleural effusion in breast cancer. Thoracoscopy for hormone receptor determination.

M N Levine, J E Young, E D Ryan, M T Newhouse.   

Abstract

Metastatic breast cancer frequently presents as a malignant pleural effusion. Knowledge of the estrogen and progesterone receptor status of the tumor predicts response to hormonal therapy, but breast cancer tissue in the pleural space is not readily accessible for hormone receptor determination. Thoracoscopy was used in six breast cancer patients with pleural effusions; all but one had concurrent sites of metastases. In five of six women recurrent breast cancer in the pleural cavity was diagnosed by thoracoscopy, and in four sufficient tissue was obtained for receptor assay. All patients achieved excellent control of their pleural effusions through a combination of local sclerotic measures and systemic therapy. Thoracoscopy is a safe procedure that can be performed under local anesthesia and is useful to visualize the pleural space, not only for diagnosis but also for obtaining breast cancer tissue for hormone receptor determination.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3942964     DOI: 10.1002/1097-0142(19860115)57:2<324::aid-cncr2820570222>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Demonstration of estrogen and progesterone receptors as well as Ki-67 and p-145 antigens in single tumor cells from blood and pleural effusions using a slide assay.

Authors:  F W Hirsch; P Deibert; H Busch; G W Löhr; K J Bross
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 2.  The role of thoracoscopy in the evaluation and management of pleural effusions.

Authors:  C Boutin; P Astoul; B Seitz
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 3.  Malignant pleural effusions: appropriate treatment approaches.

Authors:  Yener Aydin; Atila Turkyilmaz; Yavuz Selim Intepe; Atilla Eroglu
Journal:  Eurasian J Med       Date:  2009-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.